Sort
51,593 grants matching “hepatitis”
A vascularized patient-derived iPSC liver acinus microphysiology system as an innovative precision medicine platform for optimizing clinical trial design for nonalcoholic fatty liver disease
$748,638D. Lansing Taylor · University Of Pittsburgh At Pittsburgh · UG3 · FY2020 · TR
Covalent Chemistry on Nanosubstrates Enables Molecular Analysis of Purified Extracellular Vesicles in Hepatocellular Carcinoma
$748,485Hsian-Rong Tseng · University Of California Los Angeles · R01 · FY2024 · CA
Early Clinical Trials of New Anti-Cancer Agents with Phase I Emphasis
$748,484Donald W. Kufe · Dana-Farber Cancer Inst · U01 · FY2009 · CA
The role of cancer stem cells in liver cancer heterogeneity and subtypes
$748,373Xin Wang · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Coagulation Control To Protect Gaitko Lung and Liver Xenografts
$748,206Richard N Pierson · University Of Pittsburgh At Pittsburgh · U19 · FY2012 · AI
Physiological and therapeutic effects of ANGPTL3 variants in mice and humans
$748,107Marina Cuchel · University Of Pennsylvania · R01 · FY2022 · HL
Assessment of the glucagon receptor blocker REMD-477 on insulin requirements in type 1 diabetes
$748,101Samuel Klein · Remd Biotherapeutics, Inc. · R42 · FY2017 · DK
Multi-Center Validation and Biologic Assessment of a Novel Pre-Transplant Biomarker Panel to Predict Liver Transplant Recipient Mortality
$748,049Keri Elizabeth Lunsford · Rutgers Biomedical And Health Sciences · R01 · FY2024 · DK
Systems Biology Approach to Analysis of Vaccine Response in Healthy Individuals
$748,045Anna Karolina Palucka · Baylor Research Institute · U19 · FY2014 · AI
The STOP Study
$747,833Msc, Emily Westheimer · New York City Health/Mental Hygiene · U01 · FY2012 · PS
Integrated approaches to close the loop in type 1 diabetes
$747,802Yogish C. Kudva · Mayo Clinic Rochester · R01 · FY2012 · DK
TOPMed Omics of Type 2 Diabetes and Quantitative Traits
$747,659Alisa Knodle Manning · Massachusetts General Hospital · UM1 · FY2023 · DK
Assessing the impact of acquired immunodeficiency on congenital Zika virus
$747,439David H Oconnor · University Of Wisconsin-Madison · R01 · FY2019 · AI
Assessing the impact of acquired immunodeficiency on congenital Zika virus
$747,439David H Oconnor · University Of Wisconsin-Madison · R01 · FY2020 · AI
Assessing the impact of acquired immunodeficiency on congenital Zika virus
$747,439David H Oconnor · University Of Wisconsin-Madison · R01 · FY2022 · AI
Assessing the impact of acquired immunodeficiency on congenital Zika virus
$747,439David H Oconnor · University Of Wisconsin-Madison · R01 · FY2021 · AI
Mechanisms of Chronic Hepatitis B Infection and Therapeutic Vaccines
$747,395David R. Milich · Vaccine Research Institute Of San Diego · R01 · FY2008 · AI
Blocking a novel cytokine signaling pathway for the treatment of rheumatoid arthr
$747,226Kirill Ostanin · Navigen, Inc. · R44 · FY2014 · AR
Genetic Epidemiology of Complex Traits
$747,204Joan E. Bailey-Wilson · National Human Genome Research Institute · ZIA · FY2015 · HG
Phase I Trials of Anti-Cancer Agents
$747,189Michael R Grever · Ohio State University · U01 · FY2009 · CA
Dynamics of antigen specific B and Tfh responses during acute and chronic HCV
$747,129Arash Grakoui · Emory University · R01 · FY2020 · AI
Role of mitochondrial extracellular vesicles in CVB3 myocarditis by sex
$747,061Delisa Fairweather · Mayo Clinic Jacksonville · R01 · FY2022 · HL
Natural History, Therapy and Pathogenesis of Chronic Viral Hepatitis B
$747,013Marc Ghany · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2011 · DK
The Staying Safe Intervention: Preventing HCV among Young Opioid Injectors
$746,948Pedro Mateu-Gelabert · National Development And Research Institutes, Inc. · R01 · FY2017 · DA
Alcohol Metabolism, Functional Consequences and Apoptosis Signaling Mechanism
$746,941Byoung-Joon Song · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2015 · AA